首页 | 本学科首页   官方微博 | 高级检索  
     

干扰素-tau微囊的制备工艺优化
引用本文:付加雷,宋长征,张更林. 干扰素-tau微囊的制备工艺优化[J]. 中国生化药物杂志, 2007, 28(6): 378-381
作者姓名:付加雷  宋长征  张更林
作者单位:山东省医学科学院山东省医药生物技术研究中心 卫生部生物技术药物重点实验室,山东济南,250062
摘    要:目的用壳聚糖和海藻酸钠为原料,制备干扰素-tau微囊。方法采用凝聚法制备了干扰素-tau壳聚糖-海藻酸钠微囊,以包封率、微囊强度为指标,设立总的评估指数,用L9(34)表进行正交实验优化制备工艺。结果最终的优化方案为:2.0%海藻酸钠、0.4%壳聚糖、0.3%干扰素-tau以及1.0%氯化钙溶液。结论该工艺简便、稳定,壳聚糖-海藻酸钠微囊有望用作干扰素-tau或其它蛋白质药物的口服制剂技术。

关 键 词:干扰素-tau  壳聚糖  海藻酸钠  包封率  微囊
文章编号:1005-1678(2007)06-0378-04
修稿时间:2007-02-12

Optimization of the preparation of interferon tau chitosan-alginate microcapsules
FU Jia-lei,SONG Chang-zheng,ZHANG Geng-lin. Optimization of the preparation of interferon tau chitosan-alginate microcapsules[J]. Chinese Journal of Biochemical Pharmaceutics, 2007, 28(6): 378-381
Authors:FU Jia-lei  SONG Chang-zheng  ZHANG Geng-lin
Abstract:Purpose The microcapsules were prepared by using chitosan and alginate as raw materials,and the controlled-release microcapsules of interferon tau were hoped to develop an oral interferon preparation.Methods Interferon tau chitosan-alginate microcapsules were prepared by coacervation technology.Four factors and three levels for each factor were selected and arranged in an L9(34) orthogonal experimental table.The evaluating indicator(EI%),calculated according to drug encapsulated efficiency(EE%) and strength of microcapsules(MS%),was introduced as a total index for the microcapsules formulation.Results The best program is:2.0% sodium alginate,0.4% chitosan,0.3% IFN-tau and 1.0% CaCl2.Conclusion The preparation procedure is good,simple and reproducible.Chitosan-alginate microcapsules have the potential to be used in oral administration technology of interferon tau and the other protein medicines.
Keywords:interferon tau  chitosan  sodium alginate  encapsulation rate  microcapsules
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号